COLGATE PALMOLIVE CO Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Colgate Palmolive Co quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q3 2024.
  • Colgate Palmolive Co Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $737M, a 4.1% increase year-over-year.
  • Colgate Palmolive Co Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $2.87B, a 80.8% increase year-over-year.
  • Colgate Palmolive Co annual Net Income (Loss) Attributable to Parent for 2023 was $2.3B, a 28.9% increase from 2022.
  • Colgate Palmolive Co annual Net Income (Loss) Attributable to Parent for 2022 was $1.79B, a 17.6% decline from 2021.
  • Colgate Palmolive Co annual Net Income (Loss) Attributable to Parent for 2021 was $2.17B, a 19.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.87B $737M +$29M +4.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-25
Q2 2024 $2.84B $731M +$229M +45.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-26
Q1 2024 $2.61B $683M +$311M +83.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $2.3B $718M +$713M +14260% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $1.59B $708M +$90M +14.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-25
Q2 2023 $1.5B $502M -$101M -16.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-26
Q1 2023 $1.6B $372M -$187M -33.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $1.79B $5M -$143M -96.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $1.93B $618M -$16M -2.52% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $1.94B $603M -$100M -14.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $2.04B $559M -$122M -17.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $2.17B $148M -$499M -77.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $2.67B $634M -$64M -9.17% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $2.73B $703M +$68M +10.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $2.66B $681M -$34M -4.76% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $2.7B $647M +$4M +0.62% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-18
Q3 2020 $2.69B $698M +$120M +20.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $2.57B $635M +$49M +8.36% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $2.52B $715M +$155M +27.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $2.37B $643M +$37M +6.11% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-18
Q3 2019 $2.33B $578M +$55M +10.5% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-18
Q2 2019 $2.28B $586M -$51M -8.01% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-18
Q1 2019 $2.33B $560M -$74M -11.7% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-18
Q4 2018 $2.4B $606M +$283M +87.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-21
Q3 2018 $2.12B $523M -$84M -13.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-21
Q2 2018 $2.2B $637M +$113M +21.6% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-21
Q1 2018 $2.09B $634M +$64M +11.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-21
Q4 2017 $2.02B $323M -$283M -46.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
Q3 2017 $2.31B $607M -$95M -13.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-21
Q2 2017 $2.4B $524M -$76M -12.7% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-21
Q1 2017 $2.48B $570M +$37M +6.94% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-21
Q4 2016 $2.44B $606M +$1.06B Oct 1, 2016 Dec 31, 2016 10-K/A 2018-02-21
Q3 2016 $1.38B $702M -$24M -3.31% Jul 1, 2016 Sep 30, 2016 10-K/A 2018-02-21
Q2 2016 $1.4B $600M +$26M +4.53% Apr 1, 2016 Jun 30, 2016 10-K/A 2018-02-21
Q1 2016 $1.38B $533M -$9M -1.66% Jan 1, 2016 Mar 31, 2016 10-K/A 2018-02-21
Q4 2015 $1.38B -$458M -$1.09B -173% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 $2.47B $726M +$184M +33.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 $2.29B $574M -$48M -7.72% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 $2.33B $542M +$154M +39.7% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
Q4 2014 $2.18B $628M +$64M +11.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-18
Q3 2014 $2.12B $542M -$114M -17.4% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-18
Q2 2014 $2.23B $622M +$61M +10.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-18
Q1 2014 $2.17B $388M -$72M -15.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-18
Q4 2013 $2.24B $564M -$34M -5.69% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-19
Q3 2013 $2.28B $656M +$2M +0.31% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-19
Q2 2013 $2.27B $561M -$66M -10.5% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-19
Q1 2013 $2.34B $460M -$133M -22.4% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-19
Q4 2012 $2.47B $598M +$8M +1.36% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-20
Q3 2012 $2.46B $654M +$11M +1.71% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-20
Q2 2012 $2.45B $627M +$5M +0.8% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-20
Q1 2012 $2.45B $593M +$17M +2.95% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-20
Q4 2011 $2.43B $590M -$34M -5.45% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-21
Q3 2011 $2.47B $643M +$24M +3.88% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-21
Q2 2011 $2.44B $622M +$19M +3.15% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-21
Q1 2011 $2.42B $576M +$219M +61.3% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-21
Q4 2010 $2.2B $624M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-23
Q3 2010 $619M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-23
Q2 2010 $603M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-23
Q1 2010 $357M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.